抑制单羧酸转运蛋白1的表达对神经胶质瘤细胞增殖的影响
万方数据知识服务平台
应用市场
我的应用
会员HOT
万方期刊
×

点击收藏,不怕下次找不到~

@万方数据
会员HOT

期刊专题

10.3760/cma.j.issn.0253?3766.2019.03.010

抑制单羧酸转运蛋白1的表达对神经胶质瘤细胞增殖的影响

引用
目的 探讨下调单羧酸转运蛋白1( MCT1)的表达对神经胶质瘤细胞增殖抑制的分子机制.方法 将siMCT1、siMCT4和阴性对照siRNA分别转染神经胶质瘤细胞系U?251和U?87,采用四甲基偶氮唑蓝(MTT)法检测U?251和U?87细胞的增殖活性,采用克隆形成实验检测U?251和U?87细胞的克隆形成能力,采用分光光度?比色法测定U?251和U?87细胞的葡萄糖消耗量和乳酸外流量.采用Western blot法检测U?251和U?87细胞中MCT1、MCT4、葡萄糖转运蛋白1( GLUT1)、GLUT4、结节性硬化症相关蛋白2(TSC2)、p?TSC2、真核细胞翻译起始因子4E结合蛋白1(4EBP1)、p?4EBP1、S6和p?S6蛋白的表达.结果 与阴性对照组比较,siMCT1和siMCT4干扰均能明显抑制U?251和U?87细胞中MCT1和MCT4蛋白的表达(均P<0.05).但仅siMCT1转染后24~96 h,U?251和U?87细胞的细胞增殖活性明显降低(均P<0.05).干扰MCT1的表达后,U?251和U?87细胞的克隆形成率分别下降至(55.20±3.27)%和(68.33±4.58)%,与阴性对照组比较,差异均有统计学意义(均P<0.05).与72 h阴性对照组U?251和U?87细胞的葡萄糖消耗量”分别为(82.65± 6.66) pmol/L和( 63.33± 5.27) pmol/L”比较,siMCT1转染组U?251和U?87细胞的葡萄糖消耗量明显降低”分别为(31.70±3.17)pmol/L和(26.41±3.19)pmol/L,均P<0.05)”;与72 h阴性对照组U?251和U?87细胞的乳酸外流量”(155.49± 8.15)mmol/L和(135.37±8.21)mmol/L”比较,siMCT1转染组U?251和U?87细胞的乳酸外流量明显降低”分别为(42.69±4.66)mmol/L和( 38.91± 4.83) mmol/L,均P<0.05”. Western blot检测结果显示, U?251和U?87细胞转染siMCT1后能抑制GLUT1的表达,p?TSC2、p?4EBP1和p?S6蛋白的表达水平也明显降低.结论 下调MCT1表达能抑制神经胶质瘤细胞的增殖和克隆形成,其可能通过调控mTOR信号通路抑制GLUT1的表达,进而抑制其糖酵解代谢. ”Abstract” ObjectiveTo investigate the molecular mechanism of down?regulation of monocarboxylic acid transporter 1 (MCT1) on the proliferation inhibition of glioma cell.Methods siMCT1, siMCT4 and negative control siRNA were transfected into glioma cell lines including U?251 and U?87. The proliferation activities of U?251 and U?87 cells were detected by 3?(4,5?dimethyl?2?thiazolyl)?2,5?diphenyl?2H tetrazolium bromide (MTT) assay and clonogenic assay.Glucose consumption and lactic acid efflux of U?251 and U?87 cells were determined by spectrophotometry.Western blot was used to detect the expressions of MCT1, MCT4, human glucose transporter 1 ( GLUT1 ), GLUT4, tuberous sclerosis associated protein (TSC2), p?TSC2, 4E binding protein 1 (4EBP1), p?4EBP1, ribosomal S6 protein kinase (S6) and p?S6 protein in U?251 and U?87 cells. Results Compared with negative control group, siMCT1 and siMCT4 significantly inhibited the expressions of MCT1 and MCT4 protein in U?251 and U?87 cells (both P<0.05). However, only knockdown of MCT1, the proliferation activities of U?251 and U?87 cells significantly decreased (P<0.05). The clone formation rates of U?251 and U?87 cells decreased to (55.20±3.27)% and ( 68.33±4.58)%, respectively (P<0.05).The glucose consumption of U?251 and U?87 cells in the negative control group at 72 hours were ( 82.65 ± 6.66 ) pmol/L and ( 63.33 ± 5.27 ) pmol/L, respectively, significantly higher than (31.70±3.17) pmol/L and (26.41±3.19) pmol/L of the siMCT1 transfected group (P<0.05).The extracellular lactate flow of U?251 and U?87 cells in negative control group at 72 h were (155.49±8.15) mmol/L and ( 135.37 ± 8.21) mmol/L, respectively, significantly higher than (42.69± 4.66) mmol/L and (38.91±4.83) mmol/L of the siMCT1 transfected group (P<0.05).Western blot analysis showed that knockdown of MCT1 significantly decreased the protein levels of GLUT1 p?TSC2, p?4EBP1 and p?S6 in U?251 and U?87 cells. Conclusions Downregulation of MCT1 expression can inhibit the proliferation of glioma cells. Deletion of MCT1 inhibits the glycolysis and metabolism of glioma cells through regulating the mTOR signaling pathway.

神经胶质瘤、单羧酸转运蛋白1、细胞增殖、葡萄糖转运蛋白1

41

河南省科技攻关计划资助项目;Fund program;Henan Science and Technology Key Issues Plan?Funded Projects

2020-04-29(万方平台首次上网日期,不代表论文的发表时间)

共6页

208-213

相关文献
评论
暂无封面信息
查看本期封面目录

中华肿瘤杂志

0253-3766

11-2152/R

41

2019,41(3)

相关作者
相关机构

专业内容知识聚合服务平台

国家重点研发计划“现代服务业共性关键技术研发及应用示范”重点专项“4.8专业内容知识聚合服务技术研发与创新服务示范”

国家重点研发计划资助 课题编号:2019YFB1406304
National Key R&D Program of China Grant No. 2019YFB1406304

©天津万方数据有限公司 津ICP备20003920号-1

信息网络传播视听节目许可证 许可证号:0108284

网络出版服务许可证:(总)网出证(京)字096号

违法和不良信息举报电话:4000115888    举报邮箱:problem@wanfangdata.com.cn

举报专区:https://www.12377.cn/

客服邮箱:op@wanfangdata.com.cn